Literature DB >> 2103382

Radio-immunoassay for formyl methionyl leucyl phenylalanine. II. Demonstration of an enterohepatic circulation of immunoreactive bacterial chemotactic peptides in man.

E C Roberts1, C H Hobson, R P Anderson, V S Chadwick.   

Abstract

Bacterial chemotactic peptides (F-met-oligopeptides) are secreted by several species of commensal enteric bacteria and can be assayed by bioassay techniques in human colonic luminal fluid. We have previously demonstrated intestinal absorption and enterohepatic circulation of radiolabelled F-met peptides introduced into rat colon, and an eightfold increase in absorption and biliary excretion in rats with experimental colitis. This paper describes the application of a radio-immunoassay to measurements of formyl oligopeptides in human faecal dialysates, colonic and systemic venous blood and bile. All samples were fractionated by reverse-phase high performance liquid chromatography (HPLC) prior to assay. Immunoreactivity was found in faecal dialysates (5-700 nmol/L F-met-leu-phe equivalents) and bile samples (3-150 nmol/L) from normal subjects. After HPLC fractionation, up to five distinct peaks of immunoreactivity were identified. One of these co-chromatographed with authentic F-met-leu-phe; the others probably represented either closely related peptides or peptides of different chain lengths originating from the same F-met-leu-phe precursor protein. Colonic venous blood from two patients with ulcerative colitis contained immunoreactive peptide (10-30 nmol/L) and substantial immunoreactivity was found in ileostomy fluid and bile from two patients with primary sclerosing cholangitis. These results suggest the presence of an enterohepatic circulation of bacterial F-met oligopeptides in man and provide a basis for studies of the role of such pro-inflammatory peptides in patients with inflammatory bowel disease and associated hepatobiliary disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103382     DOI: 10.1111/j.1440-1746.1990.tb01766.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

2.  Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).

Authors:  P Anton; J O'Connell; D O'Connell; L Whitaker; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

3.  Microbiota-Produced N-Formyl Peptide fMLF Promotes Obesity-Induced Glucose Intolerance.

Authors:  Joshua Wollam; Matthew Riopel; Yong-Jiang Xu; Andrew M F Johnson; Jachelle M Ofrecio; Wei Ying; Dalila El Ouarrat; Luisa S Chan; Andrew W Han; Nadir A Mahmood; Caitlin N Ryan; Yun Sok Lee; Jeramie D Watrous; Mahendra D Chordia; Dongfeng Pan; Mohit Jain; Jerrold M Olefsky
Journal:  Diabetes       Date:  2019-04-22       Impact factor: 9.461

4.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

5.  Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Authors:  Walid S Maaty; Connie I Lord; Jeannie M Gripentrog; Marcia Riesselman; Gal Keren-Aviram; Ting Liu; Edward A Dratz; Brian Bothner; Algirdas J Jesaitis
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

6.  Hepatobiliary excretion of bacterial formyl-methionyl peptides in rat. Structure activity studies.

Authors:  R P Anderson; T J Butt; V S Chadwick
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

7.  Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells.

Authors:  Bo Wei; Gerhard Wingender; Daisuke Fujiwara; Diana YuHui Chen; Michael McPherson; Sarah Brewer; James Borneman; Mitchell Kronenberg; Jonathan Braun
Journal:  J Immunol       Date:  2010-01-04       Impact factor: 5.422

8.  The formyl peptide fMLF primes platelet activation and augments thrombus formation.

Authors:  Maryam F Salamah; Divyashree Ravishankar; Rajendran Vaiyapuri; Leonardo A Moraes; Ketan Patel; Mauro Perretti; Jonathan M Gibbins; Sakthivel Vaiyapuri
Journal:  J Thromb Haemost       Date:  2019-05-24       Impact factor: 5.824

9.  Bacterial MgrB peptide activates chemoreceptor Fpr3 in mouse accessory olfactory system and drives avoidance behaviour.

Authors:  Bernd Bufe; Yannick Teuchert; Andreas Schmid; Martina Pyrski; Anabel Pérez-Gómez; Janina Eisenbeis; Thomas Timm; Tomohiro Ishii; Günter Lochnit; Markus Bischoff; Peter Mombaerts; Trese Leinders-Zufall; Frank Zufall
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.